$RS

Ajemyan Arthur sold $902K of RS

Ajemyan Arthur (SVP, CFO) sold 2,200 shares of RELIANCE, INC. (RS) at $410.11 ($0.90M total) on 2026-07-31.

Original reporting
SEC EDGAR · Ajemyan Arthur
Published Aug 4, 2026, 12:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 4, 2026, 1:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RS
Neutral
low confidence
Mentioned
$RS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RSNeutralLow
01

Why it matters

The newest disclosed fact is the open-market sale size, price, and post-transaction holdings. It may slightly affect sentiment but does not change operating outlook.

02

Market read

Traders may note insider selling as a minor sentiment input, but there is no fundamental update in the text.

03

What to watch

The filing does not disclose intent, remaining compensation structure, or whether other insiders are buying; without follow-on buys or company news, signal quality is low.

Relevance 5/10Novelty 3/10Timing: filed 2026-08-04, covering a sale dated 2026-07-31

Background

The article is an SEC Form 4 insider transaction disclosure for Reliance, Inc. (RS) by CFO Ajemyan Arthur.

Company-level read

Ticker impact

$RSNeutralLow confidence
Context

RS discloses CFO Ajemyan Arthur sold 2,200 shares for about $902K via an open-market sale on 2026-07-31.

Expected impact

Likely minimal near-term impact; any reaction would be sentiment-driven and typically fades.

Evidence & confidence

Form 4 insider sales are common and often non-informational; the filing provides transaction details but no accompanying company-specific news.

Market effects

None; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

The absence of a stated 10b5-1 plan does not necessarily imply bearish information; sales can be driven by taxes, diversification, or pre-scheduled personal liquidity needs.

Key entities

  • RELIANCE, INC.

    Company filing the Form 4 insider transaction disclosure.

  • Ajemyan Arthur

    SVP, CFO who reported the open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RSHighAI 8/10

Reliance Inc (RS) (Q3 2026) Earnings Call Highlights: Record Sales and 120% EPS Growth

Reliance Inc (RS) reported Q3 2026 earnings with record sales and 120% EPS growth. However, LIFO expenses were higher than expected at $187.5M, and full-year outlook increased to $450M. Gross profit margin decreased 20 basis points to 27.9%. The U.S. Border Wall project, valued at $1.45B, is expected to be completed by Q2 2027, with Phase 2 orders already secured. Supply constraints and higher SG&A expenses could limit future growth.

$RSHighAI 8/10

Reliance Q3 Earnings Call Highlights

Reliance reported Q3 earnings with sales up 43% YoY, driven by higher shipments and pricing. Gross profit rose 12% sequentially to $1.5B, but margins were pressured by LIFO expenses and the border wall project. The company raised its full-year LIFO expense outlook to $450M. Reliance expects Q4 EPS of $7.40-$7.60, including $0.70 from the border wall contract. It also increased its share repurchase authorization to $2.5B.

$RSMedAI 8/10

Reliance: Q3 Earnings Snapshot

Reliance, Inc. (RS) reported Q3 profit of $402.9M, or $7.84 per share, beating analyst estimates of $6.76 per share. Revenue was $5.21B, exceeding expectations of $4.68B. The company forecasts Q4 EPS between $7.40 and $7.60.